Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience
{{output}}
Objectives: Biologic disease modifying anti-rheumatic drugs (bDMARDs) have significantly improved the care of patients with rheumatic muscle-skeletal disorders (RMDs). Considering their immunosuppressive action, a theoretical inc... ...
